BLOG

Monday, April 29, 2019

Dr Reddy's Laboratories, Cipla arm recall drugs from American market

The USFDA has classified both the recalls as a Class-II recall

from Companies http://bit.ly/2J1bVf4
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...